Financial Gravity Asset Management, Inc. Invitae Corp Transaction History

Financial Gravity Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$0.6 - $1.53 $42,022 - $107,156	70,037 Added 1799.51%	73,929 $44,000
Q2 2023 Aug 08, 2023	BUY	$1.05 - $1.63 $1 - $1	1 Added 0.03%	3,892 $12,000
Q1 2023 May 12, 2023	BUY	$1.2 - $2.73 $4,666 - $10,616	3,889 Added 194450.0%	3,891 $5,000
Q4 2022 Feb 15, 2023	BUY	$1.71 - $3.61 $3 - $7	2 New	2 $84,000
Q4 2021 Feb 11, 2022	SELL	$14.7 - $28.67 $0 - $0	0 Closed	0 $0

Q3 2021 Nov 12, 2021	BUY	$24.31 - $33.6 $0 - $0	0 New	0 $28,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.